Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 03, 2013 07:00 ET | Source: VIVUS, Inc.

VIVUS Names New CEO; Incumbent CEO Resigns Due to Health Concerns

MOUNTAIN VIEW, Calif., Sept. 3, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that Anthony P. Zook has resigned as Chief Executive Officer and from the VIVUS Board of Directors,...
August 27, 2013 07:30 ET | Source: VIVUS, Inc.

New Review Article Discusses Treatment of the Obese Patient in Primary Care

MOUNTAIN VIEW, Calif., Aug. 27, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that a review article has been published online in Postgraduate Medicine examining the treatment of...
August 06, 2013 16:05 ET | Source: VIVUS, Inc.

VIVUS Reports Second Quarter and First Six Months 2013 Financial Results

MOUNTAIN VIEW, Calif., Aug. 6, 2013 (GLOBE NEWSWIRE) -- VIVUS,Inc. (Nasdaq:VVUS) ("VIVUS"), which sells the obesity drug Qsymia® (phentermine and topiramate extended-release) capsules CIV in the...
August 05, 2013 07:30 ET | Source: VIVUS, Inc.

VIVUS Announces Date of Second Quarter 2013 Financial Results and Conference Call

MOUNTAIN VIEW, Calif., Aug. 5, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that it will report financial results for the second quarter ended June 30, 2013 after the Nasdaq...
August 01, 2013 07:30 ET | Source: VIVUS, Inc.

VIVUS Announces Commercial Supply Agreement With Sanofi to Produce Avanafil

MOUNTAIN VIEW, Calif., Aug. 1, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that it has entered into a Commercial Supply Agreement with Sanofi Chimie ("Sanofi"), a wholly owned...
July 22, 2013 21:15 ET | Source: VIVUS, Inc.

VIVUS Board Selects Michael Astrue as Chairman and Tony Zook as CEO

MOUNTAIN VIEW, Calif., July 22, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) ("VIVUS"), which recently began selling the obesity drug Qsymia® (phentermine and topiramate extended-release)...
July 18, 2013 23:15 ET | Source: VIVUS, Inc.

VIVUS, First Manhattan and Sarissa Capital Announce Settlement Agreement

Reconstituted Slate Will Include Six First Manhattan Nominees and Four VIVUS Nominees Anthony Zook is Expected to Serve as New CEO and to be Appointed to the Board Annual Meeting to be...
July 17, 2013 05:30 ET | Source: VIVUS, Inc.

FMC Rejects Settlement Proposal From VIVUS

VIVUS Proposal Included Leland Wilson, Chief Executive Officer, Offering to Retire VIVUS Compromise Included Board Consisting of Four Nominees From Each Side and One Independent Investor...
July 16, 2013 18:34 ET | Source: VIVUS, Inc.

VIVUS Identifies False and Misleading Statements Made by First Manhattan Co.

FMC's "Win at all Costs" Campaign Infringes on Stockholders' Rights to Make Informed Voting Decisions VIVUS Urges Stockholders to Vote FOR the Company's Nominees on the GOLD Proxy...
July 14, 2013 22:15 ET | Source: VIVUS, Inc.

First Manhattan Co.'s False and Misleading Statements Reported to the U.S. Securities and Exchange Commission

VIVUS Demands Immediate Corrective Disclosure by FMC VIVUS to Adjourn Annual Meeting of Stockholders to Thursday, July 18, 2013 Urges Stockholders to Vote FOR the Company's Nominees on the GOLD...